Drug Profile
Research programme: cocaine abuse therapeutics - Molecular Insight Pharmaceuticals
Alternative Names: Cocaine abuse therapies research programme - Molecular Insight Pharmaceuticals; CTDP 31446Latest Information Update: 05 Jan 2007
Price :
$50
*
At a glance
- Originator Harvard Medical School; Molecular Insight Pharmaceuticals
- Class
- Mechanism of Action Biogenic monoamine uptake inhibitors; Dopamine plasma membrane transport protein antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cocaine-related disorders
Most Recent Events
- 20 Jan 2003 Preclinical trials in Cocaine abuse in USA (unspecified route)